Climb Bio, Inc.
USD11.20
-0.60 (-5.08%)
CEO
Aoife Brennan BCh MMSc
IPO Date
2021-08-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.75
Prev. Close
$11.80
Day Low
$10.66
Day High
$11.75
52W Low
$1.16
52W High
$12.48
Market Cap
$0.76B
Volume
1.36M
| 16,313 |
| $7.01 |
| 27 Feb 2026 | Thomas Stephen Basil | director | S-Sale | Disposed | 33,687 | $7.00 |
| 17 Feb 2026 | Thomas Stephen Basil | director | S-Sale | Disposed | 10,000 | $5.81 |
| 17 Feb 2026 | Thomas Stephen Basil | director | S-Sale | Disposed | 90,000 | $5.23 |
| 8 Jan 2026 | Brennan Aoife | director, officer: President and CEO | A-Award | Acquired | 700,000 | $3.81 |
| 8 Jan 2026 | Wilson Perrin Megan | Chief Business Officer | A-Award | Acquired | 300,000 | $3.81 |
| 8 Jan 2026 | ALTSCHULLER Susan | Chief Financial Officer | A-Award | Acquired | 142,500 | $3.81 |
| 8 Jan 2026 | Driscoll Cindy | Senior Vice President, Finance | A-Award | Acquired | 100,000 | $3.81 |
| 7 Jan 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | P-Purchase | Acquired | 7,111 | $3.50 |